Skip to main content
HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
108.60
-3.12 (-2.79%)
Feb 21, 2025, 4:00 PM EST - Market closed

HealthEquity Revenue

HealthEquity had revenue of $300.43M in the quarter ending October 31, 2024, with 20.55% growth. This brings the company's revenue in the last twelve months to $1.15B, up 18.47% year-over-year. In the fiscal year ending January 31, 2024, HealthEquity had annual revenue of $999.59M with 16.00% growth.

Revenue (ttm)
$1.15B
Revenue Growth
+18.47%
P/S Ratio
8.18
Revenue / Employee
$365,189
Employees
3,150
Market Cap
9.41B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 31, 2024999.59M137.84M16.00%
Jan 31, 2023861.75M105.19M13.90%
Jan 31, 2022756.56M22.99M3.13%
Jan 31, 2021733.57M201.58M37.89%
Jan 31, 2020531.99M244.75M85.21%
Jan 31, 2019 Pro Pro Pro
Jan 31, 2018 Pro Pro Pro
Jan 31, 2017 Pro Pro Pro
Jan 31, 2016 Pro Pro Pro
Jan 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

HQY News

More News